Your browser doesn't support javascript.
loading
Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial.
Kong, Fei; Wen, Xiaoyu; Wen, Xiaofeng; Wang, Xiaozhong; Wu, Guicheng; Lin, Shide; Wang, Li; Xing, Huichun; Yan, Xuebing; Zheng, Sujun; Ning, Qin; Wang, Zheng; Zhang, Liaoyun; Lin, Jianmei; Tong, Zhaowei; Huang, Chengyu; Su, Minghua; Tong, Lixin; Jia, Jidong; Xin, Yongning; Zhu, Qingjing; Wang, Jing; Chen, Li; Li, Xiaowen; Wu, Xuegang; Niu, Duan; Liu, Quan; Wei, Wei; Zhang, Yuexin; Li, Guangming; Niu, Junqi.
  • Kong F; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
  • Wen X; Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.
  • Wen X; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
  • Wang X; Department of Hepatology, Liuzhou People's Hospital, Liuzhou, China.
  • Wu G; Department of Hepatology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Urumqi, China.
  • Lin S; Department of Hepatology, Chongqing University Three Gorges Hosipital, Chongqing Three Gorges Central Hospital, Chongqing, China.
  • Wang L; Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Xing H; Department of Hepatology, Public Health Clinical Center of Chengdu, Chengdu, China.
  • Yan X; Department of Hepatology Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zheng S; Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Ning Q; Difficult and Complicated Liver Diseases and Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
  • Wang Z; Department of Infectious Diseases, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang L; Department of Infectious Diseases, Wuxi No. 5 People's Hospital, Wuxi, China.
  • Lin J; Department of Infectious Diseases, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
  • Tong Z; Department of Infectious Diseases, Sichuan Provincial People's Hospital, Chengdu, China.
  • Huang C; Department of Infectious Diseases, Huzhou Central Hospital, Huzhou, China.
  • Su M; Department of Hepatology, Chongqing Public Health Medical Center, Chongqing, China.
  • Tong L; Department of Infectious Disease, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Jia J; Center of Liver Diseases, The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
  • Xin Y; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhu Q; Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, China.
  • Wang J; Department of Hepatology, Wuhan Public Health Medical Center, Wuhan, China.
  • Chen L; Department of Hepatology, The Affiliated TCM Hospital of Southwest Medical University, Luzhou, China.
  • Li X; General Manager Office, Shanghai Viromedicine Co., Ltd., Shanghai, China.
  • Wu X; General Manager Office, Shanghai Viromedicine Co., Ltd., Shanghai, China.
  • Niu D; Department of Clinical Research, Shanghai Viromedicine Co., Ltd., Shanghai, China.
  • Liu Q; Department of Clinical Research, Shanghai Viromedicine Co., Ltd., Shanghai, China.
  • Wei W; Department of Emerging Infectious Diseases, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, China.
  • Zhang Y; Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, China.
  • Li G; Department of Infectious Diseases, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Niu J; Cirrhosis Department, Zhengzhou Sixth Municipal People's Hospital, Zhengzhou, China.
J Gastroenterol Hepatol ; 36(9): 2375-2382, 2021 Sep.
Article en En | MEDLINE | ID: mdl-33491236

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas no Estructurales Virales / Hepatitis C Crónica / Sofosbuvir Tipo de estudio: Clinical_trials Límite: Adult / Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas no Estructurales Virales / Hepatitis C Crónica / Sofosbuvir Tipo de estudio: Clinical_trials Límite: Adult / Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article